Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 4.12 Description of Securities
- 21.1 Subsidiaries of the Registrant
- 23.1 Consents of Experts and Counsel
- 23.2 Consents of Experts and Counsel
- 31.1 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 31.2 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 32.1 Certificate Pursuant to Section 18 U.s.c. Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
Related press release
Associated NDRA transcripts
NDRA similar filings
Filing view
External links
Exhibit 23.2
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the incorporation by reference in the Registration Statements of ENDRA Life Sciences Inc. on Form S-8 (File Nos. 333-233178 and 333-218894) of our report dated March 26, 2020, with respect to our audits of the consolidated financial statements of ENDRA Life Sciences Inc. & Subsidiary as of December 31, 2019 and 2018, which is included in this Annual Report on Form 10-K of ENDRA Life Sciences Inc.
/s/ RBSM LLP
RBSM LLP
Henderson, NV
March 26, 2020